72457-43-3

Basic information

• Product Name: 3-(4-ethoxyphenyl)propan-1-ol
• Synonyms: 3-(4-ethoxyphenyl)propan-1-ol
• CAS NO: 72457-43-3
• Molecular Weight: 180.247
• Mol File: 72457-43-3.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 3-(4-ethoxyphenyl)propan-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(4-ethoxyphenyl)propan-1-ol(72457-43-3)
• EPA Substance Registry System: 3-(4-ethoxyphenyl)propan-1-ol(72457-43-3)

Safety Data

• Hazardous Substances Data: 72457-43-3(Hazardous Substances Data)

Upstream product

• 2373-79-7 (E)-4-ethoxycinnamic acid 
• 2373-79-7 4-ethoxycinnamic acid 
• 124-38-9 carbon dioxide 
• 10210-17-0 3-(4-hydroxyphenyl)propan-1-ol 
• 75-03-6 ethyl iodide 
• 75-85-4 tert-Amyl alcohol 
• 75332-46-6 (E)-ethyl 3-(4-ethoxyphenyl)acrylate 

Downstream Products

• 854827-68-2 [3-(4-ethoxy-phenyl)-propyl]-malonic acid 
• 749250-48-4 5-(4-ethoxy-phenyl)-valeric acid 
• 34670-10-5 5-(4-ethoxy-phenyl)-5-oxo-valeric acid 
• 70080-55-6 (4-ethoxy-phenyl)-glyoxylic acid 
• 619-86-3 4-(ethoxy)benzoic acid 
• 720682-47-3 4-(3-bromo-propyl)-phenetole 

Relevant articles and documents

Formononetin derivatives and preparation methods and medical application thereof

The invention relates to the field of pharmaceutical chemistry, and relates to formononetin derivatives and preparation methods and medical application thereof, in particular to formononetin derivatives with the general formula as shown in (I), preparation methods thereof, pharmaceutical compositions containing the compounds and medical application of the derivatives and the pharmaceutical compositions, particularly, application of the derivatives and the pharmaceutical compositions serving as drugs for preventing or treating hyperlipidaemia or obesity or type-II diabetes. Please see the formula in the description.

Synthesis and fungicidal activity study of novel daphneolone analogs with 2,6-dimethylmorpholine

A series of novel daphneolone analogs was designed and synthesized on the basis of natural product 1,5-diphenyl-2-penten-1-one (I) from Stellera chamaejasme L. as lead compound, whereby 2,6-dimethylmorpholine moiety was introduced to replace 1-phenyl group. Their structures were confirmed by IR, 1H NMR, and HRMS (ESI) or elemental analysis, 13C NMR for some representative compounds. The two isomers of target compounds were separated and identified by NOESY technique and chemical method. All of the synthesized compounds have been evaluated for anti-plant pathogenic fungi activities. The results showed that some compounds exhibited moderate to good antifungal activities against tested fungi at the concentration of 50 mg/L. Among them, compound 7d, with a 4-bromine-substituted phenyl group and cis-2,6-dimethylmorpholine moiety, displayed best activity with an EC50 of 23.87 μmol/L against Valsa Mali, superior to lead compound I. In addition, preliminary structure-activity relationship analysis indicated that, between two isomers of target compounds, the antifungal activities of the isomer with cis-2,6-dimethylmorpholine were better than the trans-isomer.

Quaternary ammonium antiarrhythmic drugs

Quaternary ammonium salts of certain phenylbutylamines are useful antiarrhythmic drugs. A method for treating arrhythmia and prolonging the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such quaternary ammonium salts are disclosed.